Nicholas Investment Partners, LP Mirati Therapeutics, Inc. Transaction History

Nicholas Investment Partners, LP

  • $900 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022
SELL
$75.82 - $150.97 $9.71 Million - $19.3 Million
-128,125 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$132.01 - $190.29 $1.07 Million - $1.54 Million
8,102 Added 6.75%
128,125 $18.8 Million
Q3 2021

Nov 15, 2021
BUY
$132.13 - $177.45 $189,210 - $254,108
1,432 Added 1.21%
120,023 $21.2 Million
Q2 2021

Aug 10, 2021
BUY
$144.0 - $179.73 $17.1 Million - $21.3 Million
118,591 New
118,591 $19.2 Million

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email